A detailed history of American Portfolios Advisors transactions in Verastem, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 2,985 shares of VSTM stock, worth $9,701. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,985
Holding current value
$9,701
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$0.92 - $1.37 $2,746 - $4,089
2,985 New
2,985 $2.54 Million
Q4 2021

Mar 21, 2023

SELL
$2.05 - $3.2 $2,050 - $3,200
-1,000 Reduced 33.5%
1,985 $4.07 Million

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $683M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.